← Browse by Condition

Medical Condition

nasopharyngeal carcinoma

Total Trials

12

Recruiting Now

12

Trial Phases

Phase 2, Phase 3

NCT06019130 Phase 2

Nivolumab in Children and Adults With Nasopharyngeal Carcinoma

German Society for Pediatric O...

Surgery Alone Verus Sugery Combined with Dose-reduced Radiotherapy for Newly Diagnosed Stage I Nasopharyngeal Carcinoma

NCT06383780 Phase 3

Tislelizumab in Combination With GP or TPC Regimen for the Treatment of Nasopharyngeal Carcinoma With Bone Metastasis.

Epstein-Barr Virus Antibody and Epstein-Barr Virus DNA for Nasopharyngeal Carcinoma Screening

Sun Yat-sen University

NCT04437329 Phase 3

Nedaplatin Versus Cisplatin in Treatment for Nasopharyngeal Carcinoma

Affiliated Cancer Hospital & I...

Sequencing-based Counting of Plasma Epstein-Barr Virus DNA in Non-metastatic Nasopharyngeal Carcinoma

Hunan Cancer Hospital

NCT05097209 Phase 2

Camrelizumab for the Treatment of Locally Advanced Nasopharyngeal Carcinoma

NCT06592599 Phase 2

Gemcitabine + Docetaxel + Toripalimab Induction in Epstein-Barr Virus (EBV) Associated Nasopharyngeal Carcinoma(NPC)

Stanford University

NCT04898374 Phase 3

Induction Versus Adjuvant Gemcitabine/Cisplatin in Locally Advanced Non-metastatic Nasopharyngeal Carcinoma

Kuwait Cancer Control Center

NCT05342792 Phase 3

Metronomic Capecitabine With or Without PD-1 Antibody as Adjuvant Therapy in High-risk Nasopharyngeal Carcinoma

Sun Yat-sen University

NCT04813705 Phase 2

18F-FDG PET/CT Guided Reduced-dose Radiotherapy for Nasopharyngeal Carcinoma

Taizhou Hospital

NCT06241612 Phase 3

Individualized Elective Neck Irradiation in NPC Patients

Sun Yat-sen University